Short- and Long-Term Visual Outcomes in Patients Receiving Intravitreal Injections: The Impact of the Coronavirus 2019 Disease (COVID-19)—Related Lockdown.

MLA

Douglas, Vivian Paraskevi, et al. “Short- and Long-Term Visual Outcomes in Patients Receiving Intravitreal Injections: The Impact of the Coronavirus 2019 Disease (COVID-19)—Related Lockdown.” Journal of Clinical Medicine, vol. 11, no. 8, Apr. 2022, p. 2097. EBSCOhost, https://doi.org/10.3390/jcm11082097.

APA

Douglas, V. P., Douglas, K. A. A., Vavvas, D. G., Miller, J. W., & Miller, J. B. (2022). Short- and Long-Term Visual Outcomes in Patients Receiving Intravitreal Injections: The Impact of the Coronavirus 2019 Disease (COVID-19)—Related Lockdown. Journal of Clinical Medicine, 11(8), 2097. https://doi.org/10.3390/jcm11082097

Chicago

Douglas, Vivian Paraskevi, Konstantinos A. A. Douglas, Demetrios G. Vavvas, Joan W. Miller, and John B. Miller. 2022. “Short- and Long-Term Visual Outcomes in Patients Receiving Intravitreal Injections: The Impact of the Coronavirus 2019 Disease (COVID-19)—Related Lockdown.” Journal of Clinical Medicine 11 (8): 2097. doi:10.3390/jcm11082097.